Zurich Insurance Group Ltd FI Increases Stock Position in Stryker Co. (NYSE:SYK)

Zurich Insurance Group Ltd FI lifted its holdings in Stryker Co. (NYSE:SYK - Free Report) by 0.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 188,544 shares of the medical technology company's stock after buying an additional 794 shares during the period. Zurich Insurance Group Ltd FI's holdings in Stryker were worth $67,885,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Stryker in the 4th quarter worth about $25,000. Rakuten Securities Inc. increased its holdings in shares of Stryker by 618.2% in the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after buying an additional 68 shares during the last quarter. Centricity Wealth Management LLC bought a new stake in shares of Stryker in the 4th quarter worth about $30,000. BankPlus Trust Department bought a new stake in shares of Stryker in the 4th quarter worth about $33,000. Finally, Activest Wealth Management bought a new stake in shares of Stryker in the 4th quarter worth about $36,000. 77.09% of the stock is currently owned by institutional investors.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the sale, the director now owns 3,417,326 shares of the company's stock, valued at $1,288,195,208.96. This represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 5.90% of the stock is currently owned by corporate insiders.

Stryker Price Performance

Shares of SYK opened at $394.63 on Tuesday. The company has a 50 day moving average price of $367.24 and a 200-day moving average price of $375.80. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The stock has a market capitalization of $150.63 billion, a PE ratio of 50.85, a PEG ratio of 2.93 and a beta of 0.93. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, topping the consensus estimate of $2.73 by $0.11. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The firm had revenue of $5.87 billion during the quarter, compared to analysts' expectations of $5.68 billion. During the same quarter in the prior year, the company earned $2.50 EPS. The company's revenue was up 11.9% compared to the same quarter last year. Equities analysts predict that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.85%. Stryker's payout ratio is 45.41%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on SYK. Needham & Company LLC restated a "buy" rating and issued a $442.00 target price on shares of Stryker in a report on Friday, March 21st. Stifel Nicolaus upped their price target on shares of Stryker from $400.00 to $440.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. JMP Securities reiterated a "market perform" rating on shares of Stryker in a report on Monday, May 5th. JPMorgan Chase & Co. upped their price target on shares of Stryker from $420.00 to $445.00 and gave the company an "overweight" rating in a report on Wednesday, January 29th. Finally, Sanford C. Bernstein set a $450.00 price target on shares of Stryker in a report on Monday, May 5th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $427.05.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.